Soluble Suppression of Tumorigenicity 2 (sST2) as a Diagnostic and Prognostic Marker in Acute Heart Failure and Sepsis: A Comparative Analysis

Soluble Suppression of Tumorigenicity 2 (sST2) as a Diagnostic and Prognostic Marker in Acute Heart Failure and Sepsis: A Comparative Analysis

<b>Background:</b> Suppression of Tumorigenicity 2 (ST2), a member of the interleukin-1 receptor family, plays a crucial role in immune regulation. Elevated sST2 levels are associated with poor prognosis in various inflammatory and cardiovascular diseases, including acute heart failure (...

Full description

Saved in:

Bibliographic Details
Main Authors:	Flavio Davini, Marta Fogolari, Giorgio D’Avanzo, Maria Vittoria Ristori, Serena Nucciarelli, Lucrezia Bani, Antonio Cristiano, Marina De Cesaris, Silvia Spoto, Silvia Angeletti
Format:	Article
Language:	English
Published:	MDPI AG 2025-04-01
Series:	Diagnostics
Subjects:	biomarkers ST2 suppression of tumorigenicity 2 diagnostic marker prognostic marker acute heart failure
Online Access:	https://www.mdpi.com/2075-4418/15/8/1010
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prognostic value of serum HDAC2 and sST2 in occupational asthma patients
by: Ruifeng FENG, et al.
Published: (2024-11-01)

Association between soluble suppression of tumorigenicity 2 and risk and severity of coronary artery disease: a case control study
by: Shuai Zhang, et al.
Published: (2025-04-01)

Soluble suppression of tumorigenicity 2 associated with microvascular obstruction in patients with ST-segment elevation myocardial infarction
by: Xinjia Du, et al.
Published: (2024-11-01)

Soluble suppression of tumorigenicity 2 associated with left ventricular thrombosis in patients with ST-segment elevation myocardial infarction
by: Xinjia Du, et al.
Published: (2025-03-01)

The clinicopathological implications of serum IL-33 and sST2 as cancer biomarkers: A narrative review
by: Swetha Acharya, et al.
Published: (2025-05-01)

DGKα Enhances Tumorigenic Activity in Bladder Cancer Patients With Chronic Kidney Disease
by: Kenshiro Takemoto, et al.
Published: (2025-03-01)

sST2 levels and 3D speckle tracking as predictors of CAD severity in chronic coronary syndrome
by: Amr Setouhi, et al.
Published: (2024-12-01)

Extruded nanovesicles derived from umbilical cord mesenchymal stem cells exhibit No tumorigenic potential
by: Fei Wang, et al.
Published: (2025-10-01)

Short-term predictive value of sST2 in patients with STEMI following primary PCI: a prospective observational study
by: Shan Huang, et al.
Published: (2025-01-01)

Transcriptional Factors Related to Cellular Kinetics, Apoptosis, and Tumorigenicity in Equine Adipose-Derived Mesenchymal Stem Cells (ASCs) Are Influenced by the Age of the Donors
by: Ekaterina Vachkova, et al.
Published: (2025-06-01)

miR-10b-5p promotes tumor growth by regulating cell metabolism in liver cancer via targeting SLC38A2
by: Mingzhi Xia, et al.
Published: (2024-12-01)

IL-33/ST2 axis in diverse diseases: regulatory mechanisms and therapeutic potential
by: Feiya Sheng, et al.
Published: (2025-01-01)

Phenotypic characterization and complete genome of a tumorigenic pathobiont Escherichia coli LI60C3
by: Linda Chia-Hui Yu, et al.
Published: (2025-08-01)

Vorinostat impairs the cancer-driving potential of leukemia-secreted extracellular vesicles
by: Crescenzo Massaro, et al.
Published: (2025-04-01)

Development of a prognostic model for chemotherapy response and identification of TNFAIP2 as a target in colorectal cancer
by: Cheng Zhou, et al.
Published: (2025-06-01)

EPHX2 overexpression deters the advancement of clear cell renal cell carcinoma via lipid metabolism reprogramming
by: Bo Guan, et al.
Published: (2025-06-01)

Role of paraoxonase 2 (PON2) as a potential biomarker and therapeutic target in cancer treatment
by: Vinayak Agarwal, et al.
Published: (2025-08-01)

Genome-wide development of simple sequence repeat (SSR) markers at 2-Mb intervals in lotus (Nelumbo Adans.)
by: Fengluan Liu, et al.
Published: (2025-01-01)

Association between simple, combined lipid markers and 20-year cumulative incidence of type 2 diabetes: the ATTICA cohort study (2002–2022)
by: Ioanna Kechagia, et al.
Published: (2024-12-01)

Pharmacogenetics of statin therapy and the endothelial function parameters in patients with type 2 diabetes mellitus
by: Nadezhda O. Lebedeva, et al.
Published: (2016-07-01)

CD40 ligand in coronary heart disease patients with Type 2 diabetes mellitus
by: O. P. Shevchenko, et al.
Published: (2006-10-01)

Ability of soluble TREM2 and PRO-C3 as biomarkers to predict changes in MASLD activity
by: Charlotte Wilhelmina Wernberg, et al.
Published: (2025-08-01)

Exploring biomarkers and molecular mechanisms of Type 2 diabetes mellitus promotes colorectal cancer progression based on transcriptomics
by: Simin Luo, et al.
Published: (2025-02-01)

Are inflammatory markers criteria for predicting mortality in covid-19 patients?
by: Katayoun Ziari, et al.
Published: (2021-12-01)

Le principe de surprise annoncée
by: Christiane Marchello-Nizia
Published: (2017-10-01)

Development and validation of a functional molecular marker for a CaAPRR2-like gene that controls green fruit colour in pepper
by: Ting Zhang, et al.
Published: (2024-12-01)

CYP2C9 Polymorphism is not Associated with Elevated Carcinoembryonic Antigen Levels
by: Claire Hall, et al.
Published: (2019-04-01)

Invasive plant Lupinus polyphyllus demonstrates high level of molecular genetic variation within and between populations at East European Plain
by: Maria A. Galkina, et al.
Published: (2025-04-01)

Scoping review: (Bio)markers for the prognostication of breast cancer recurrence
by: Rigon Sallauka, et al.
Published: (2025-07-01)

Construction of an integrated linkage map of sugarcane using unigene-derived microsatellite (SSR) markers
by: Sujeet P. Singh, et al.
Published: (2025-03-01)

Morphological and genetic polymorphism of the introduced population of <i>Prunus pumila</i> L. in Chelyabinsk Province
by: M. S. Lezin, et al.
Published: (2021-04-01)

Predicting incident type 2 diabetes in a Japanese cohort: an 8-year analysis of the NAGALA database
by: Yangchun Wang, et al.
Published: (2025-05-01)

ARIH2 serves as a potential prognostic biomarker for hepatocellular carcinoma associated with immune infiltration and ferroptosis
by: Qiang Shu, et al.
Published: (2025-04-01)

Metabolic patterns of new psychoactive substances: Methyl-ketamine and 2-oxo-PCE in rats using UHPLC-QTOF analysis
by: Yu-gang Cai, et al.
Published: (2025-12-01)

EZH2: An analysis of a potential new tumor marker in high-risk localization of cutaneous squamous cell carcinomas
by: Cristian-Viktor Valea, et al.
Published: (2025-03-01)

Clinical and Clinico-Pathological Observations of the Erythrocyte Sedimentation Rate in Dogs Affected by Leishmaniosis and Monitored During Antileishmanial Treatment
by: George Lubas, et al.
Published: (2025-06-01)

Post-COVID-19 cardiovascular complications in children. Description of clinical cases
by: V.R. Mishchuk, et al.
Published: (2024-10-01)

Comprehensive Genetic and Morphological Analysis of Algerian Carob (<i>Ceratonia siliqua</i> L.) Accessions
by: Oussama Smaili, et al.
Published: (2025-03-01)

Comprehensive analysis of the prognostic and immunological role of cavins in non-small cell lung cancer
by: Kelin Mou, et al.
Published: (2024-12-01)

Diagnostic utility of Th2 cytokines (IL-4, IL-5, IL-10, and IL-13) in pulpal blood for assessing pulpitis severity
by: Qun Li
Published: (2025-04-01)